INDIANAPOLIS — An Indianapolis man was sentenced to more than 19 years in federal prison this week after pleading guilty to two robberies and brandishing a firearm.
Dujuan Lucas, 22, was sentenced to 231 months for crimes committed in August 2020.
According to court documents, on August 8, 2020, Victim 1 contacted Lucas, who had listed a vehicle for sale under a fictitious name, on the internet-based marketplace OfferUp.
During their meetup in the area of Redskin Lane in Indianapolis, Lucas reportedly pointed a pistol at the head of the victim and stole $1,000 from them.
On Aug. 23, 2020, according to court documents, a separate victim met Lucas after he had listed an iPhone 11 on Facebook Marketplace. During their meetup, Lucas grabbed the victim and pointed a gun at their head.
The victim’s friends were demanded to give Lucas money and their cell phones, according to court documents.
According to court records, this was not Lucas’s first run-in with authorities for armed robbery. In 2016 Lucas was convicted of armed robbery as a juvenile.
Lucas was out on bond awaiting trial for narcotics charges in Marion County at the time he committed the two marketplace robberies.
-
Indiana lawmaker proposes state takeover of public safety downtown
Safety in the city’s core is a frequent topic of discussion following violent crimes. Now, one state lawmaker has introduced legislation that would allow the state to step in.
Hoosier cities embracing AI technology to boost efficiency
Carmel is among the communities embracing AI to boost municipal efficiency. The city sees the technology as a tool to improve operations and deliver better services to residents.
Cicero homeowner concerned about proposed lithium battery facility
A rezoning proposal for a new battery storage facility in Cicero is drawing concerns from nearby residents who worry about noise, light pollution and potential safety risks.
AG Rokita files lawsuit against Indiana-based Eli Lilly over cost of insulin
Indiana Attorney General Todd Rokita has filed a lawsuit against Indiana-based Eli Lilly, accusing the drug company of "participating in a scheme with other insulin manufacturers," inflating prices.
